Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development  by Miyazaki, Yoichi et al.
Kidney International, Vol. 63 (2003), pp. 835–844
Evidence that bone morphogenetic protein 4 has multiple
biological functions during kidney and urinary tract development
YOICHI MIYAZAKI, KEISUKE OSHIMA, AGNES FOGO, and IEKUNI ICHIKAWA
Departments of Pediatrics, Pathology, and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; and
Department of Pediatrics, Tokai University Hospital, Kanagawa, Japan
filter. Thus, BMP4 can serve as a chemoattractant for periure-Evidence that bone morphogenetic protein 4 has multiple bio-
teral mesenchymal cells and induce locally the smooth musclelogical functions during kidney and urinary tract development.
layer of the ureter at Bmp4-expressing sites.Background. We have suggested that bone morphogenetic
Conclusion. Depending on local context, BMP4 has severalprotein 4 (BMP4), acting on the Wolffian duct and ureter
biological actions on the morphogenesis of different portionsepithelium, determines the budding site of the ureter by locally
antagonizing ubiquitous inductive signal(s) from the meta- of the excretory system, namely, the development of the ureter-
nephric mesenchyme. In the present study, we examine the ovesical junction, the ureter, and the kidney.
effect of BMP4 on the development of metanephric and peri-
ureteral mesenchymal cells, which express the BMP type I re-
ceptor gene, Bmpr1a (Alk3).
Bone morphogenetic protein 4 (BMP4), a member ofMethods. Urogenital tissues obtained from Bmp4 heterozy-
the transforming growth factor- (TGF-) superfamily,gous null mutant (Bmp4/) embryos at different stages, and
metanephric and ureteral tissue explants cultured in the pres- has been implicated in several aspects of embryonic de-
ence of recombinant BMP4 were subjected to morphologic, velopment, from establishment of the basic embryonic
immunohistochemical and in situ hybridization analyses. To
body plan to morphogenesis of some organs, by regulat-examine the chemotactic activity of BMP4 for periureteral
ing cell proliferation, differentiation, apoptosis, and che-mesenchymal cells, a modified Boyden chamber assay was per-
formed. motaxis [1]. We showed earlier [2] that mice heterozy-
Results. Many of the kidneys of newborn Bmp4 / mice gous for a null mutation in the Bmp4 gene (Bmp4 /)
contained multicystic dysplastic regions. This morphology was exhibit anomalies that anatomically and histologicallypreceded by abnormally high apoptotic activity in the meta-
mimic human congenital anomalies of the kidney andnephric mesenchyme of mutant embryos at E14.5. In whole
urinary tract (CAKUT) [3]. Thus, a diverse spectrum ofmetanephric explants, BMP4 uniformly promoted the expan-
sion of the Pax2-negative and weakly Foxd1 (previously Bf2) anomalies appears within one litter, including hypo/dys-
-positive peripheral stromal compartment of metanephric mes- plastic kidneys, hydroureter, ectopic ureterovesical junc-
enchyme in the presence of fibroblast growth factor 2 (FGF2).
tion, and double collecting system. The study suggestedIn addition, in isolated metanephric mesenchyme, BMP4-
that BMP4 has important functions in controlling theloaded beads prevented apoptosis locally. Thus, BMP4 pre-
vents cell death and promotes the growth of the metanephric site of budding of the ureter from the epithelium of the
mesenchyme. The effect of BMP4 on periureteral mesenchyme Wolffian duct, and the branching of the ureter bud itself.
is different from its effect on metanephric mesenchyme. In BMP4 appears to accomplish these by locally antagoniz-utero, periureteral mesenchymal cells condense around the
ing bud-inducing signal(s) from the metanephric mesen-ureter epithelium, followed by differentiation into smooth mus-
chyme that are acting ubiquitously on the duct and thecle cells at a site where Bmp4 is intensely expressed. Analysis
of Bmp4/ ureters at E15.5 reveals that the-smooth muscle ureter and by promoting the growth and elongation of
actin (-SMA)–positive cells are low in number. In vitro, the ureter bud, respectively. A deficiency in the level of
BMP4-loaded beads promote the accumulation of periureteral
BMP4 causes ectopic and accessory budding and reducedmesenchymal cells to form several cell layers surrounding the
branching of the ureter in Bmp4/ embryos. These de-beads. In addition, in a Boyden chamber assay, BMP4 increases
the migration of periureteral mesenchymal cells through the fects lead to ectopic ureterovesical junction and double
collecting system, and to hypoplastic kidney, respectively.
Ectopic ureterovesical junction is linked to the devel-Key words: apoptosis, bone morphogenetic protein, chemotaxis, ex-
plant culture, metanephric mesenchyme, mouse, mutant, smooth muscle. opment of CAKUT, as it leads to megaureter, ureter-
ovesical junction obstruction, vesicoureteral reflux, and
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hypo/dysplastic kidney [4]. In Bmp4 / mutants, how-and in revised form October 17, 2002
Accepted for publication October 21, 2002 ever, some of the kidney and ureter anomalies are seen
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at 4 m. The sections were routinely stained with hema-In addition, Bmp4 continues to be expressed throughout
toxylin for qualitative and quantitative analyses.the embryonic kidney and urinary tract system beyond
the stage of initial ureteral budding from the Wolffian
In situ hybridizationduct. Likewise, the BMP type Ia receptor gene (Alk3) is
Whole-mount in situ hybridization with digoxigenintranscribed in the metanephric and periureteral mesen-
(DIG) uridine triphosphate (UTP)-labeled antisense ribo-chymes, as well as in the epithelium [2, 5, 6]. It is conceiv-
probes and histologic section in situ hybridization usingable, therefore, that BMP4 can have diverse regulatory
35S-labeled antisense probes were performed as describedroles in the growth and differentiation of mesenchymes
previously [2]. The following mouse cDNA fragmentsin different regions of the developing kidney.
were used as templates: 0.3 kb Pax2 cDNA [2], 0.9 kbBy performing experiments on Bmp4 / embryonic
Foxd1 (previously Bf2) cDNA (provided by Dr. Tsutomutissues in vivo and cultured explants in vitro, we found
Kume, Vanderbilt University Medical Center, Nashville,that BMP4 can have several other specific biological
TN, USA), and 0.9 kb Bmp7 cDNA [8].actions in the ontogeny of the excretory system.
Detection of programmed cell death
METHODS Cell death was examined in whole tissues and sections.
Explants were incubated in the medium with 2.5 g/mLMice
propidium iodide (Boehringer Mannheim, Indianapo-F2 male Bmp4 heterozygous null mutant mice
lis, IN, USA) for 30 minutes at 37C. Tissues were then(Bmp4lacZneo) [7] on the 129/SvEv x Black Swiss genetic
washed in large volume of the medium without propid-background were serially backcrossed with C57BL/6
ium iodide for 30 minutes. Labeled cells were detectedfemales (The Jackson Laboratory, Bar Harbor, ME,
using a Zeiss Universal fluorescence microscope (CarlUSA), as described [2]. Heterozygous (Bmp4lacZneo /)
Zeiss, Oberkochen, Germany). To analyze apoptotic cellsand wild-type (/) mice between N2 and N5 genera-
in sections, the TUNEL assay was performed using the
tions were used in the present study. The Bmp4lacZneo ge- ApoTag detection kit (Intergen, Purchase, NY, USA) and
notype was determined by polymerase chain reaction Apoptosis detection kit (Promega, Madison, WI, USA),
(PCR) analysis for the neo gene with the following primer according to the manufacturers’ protocol. Six nonadjacent
sequences: neo1, 5-TCCTGCCGAGAAAGTATCCA coronal sections from embryonic kidneys were examined
TCAT-3, and neo2, 5-GTAAAGCACGAGGAAGC and the percentage of terminal deoxy transferase uridine
GGTCAGC-3. triphosphate nick end-labeling (TUNEL)–positive nuclei
against total nuclei was determined for the metanephricExplant culture
mesenchymal area.
Kidney rudiments were dissected from E11.5 wild-type
embryos. To obtain isolated metanephric mesenchymes, Immunostaining for -smooth muscle actin
the kidney rudiments were soaked in 0.02% ethylendia- The sections were stained for -smooth muscle actin
mine tetraacetic acid (EDTA, pH 8.0) for 15 minutes, (-SMA), with an antihuman -SMA antibody (DAKO,
and the mesenchyme was manually separated from the Carpinteria, CA, USA), following the manufacturer’s pro-
ureteric bud with a 27 G needle. In the experiments on tocol. The density of -SMA expressing cells was deter-
the mesenchyme surrounding the ureter epithelium, the mined as a percentage of the -SMA positive cells against
ureter and a part of the Wolffian duct, but not the meta- total mesenchymal cells surrounding the epithelium at
nephros, was dissected from E11.5-12.0 embryos. Ex- the most cranial portion of the ureter.
plants of the whole kidney, the isolated metanephric
Cell migration assaymesenchyme, or the ureter were cultured as described
previously [2]. In some experiments, the medium was sup- Ureters from E12.0 embryos were treated with 0.02%
plemented with human recombinant BMP4 (R&D Sys- ethylenediaminetetraacetic acid (EDTA), and the epi-
tems, Inc., Minneapolis, MN, USA) or fibroblast growth thelium was then manually removed. The remaining per-
factor 2 (FGF2; R&D Systems, Inc.). Affi-Gel Blue beads iureteral mesenchyme was dissociated into single cells
(100 to 200 mesh, 75 to 150 m; Bio-Rad Laboratories, with 0.1% tripsin-EDTA (GIBCO BRL, Gaithersburg,
Inc., Hercules, CA, USA) soaked with BMP4 or BMP7 MD, USA) and 0.2% collagenase A (Boehringer Mann-
(R&D Systems, Inc.), or heparin acrylic beads (Sigma heim) for 60 minutes at 37C followed by pipetting. Af-
Chemical Company, St. Louis, MO, USA) soaked with ter resuspended in Dulbecco’s modified Eagle’s medium
FGF2 were prepared as described [2]. (DMEM) containing 20% fetal bovine serum (FBS),
cells were subjected to a modified Boyden chamber
Histology assay. Recombinant BMP4 or platelet-derived growth
Samples were fixed in 4% buffered paraformaldehyde, factor (PDGF)–BB (R&D Systems, Inc.) was added to
the bottom chamber or both the bottom and the toproutinely processed, embedded in paraffin and sectioned
Fig. 1. Apoptosis in the metanephric mes-
enchyme of Bmp4 / embryos. Sections
from wild-type (A) and mutant (B) kidneys
at E14.5 were subjected to terminal deoxy
transferase uridine triphosphate nick end-
labeling (TUNEL) staining. Many TUNEL-
positive cells (stained in brown) are seen in the
peripheral mesenchymal area of Bmp4 /
mutants (arrows). Bars are 200 m. An adja-
cent section of (B) was subjected to in situ
hybridization with Pax2 (C ) or Foxd1 probes
(D). TUNEL positive cells in (B) were present
in Pax2-negative and Foxd1-positive area of
the metanephric mesenchyme (arrows). Sec-
tions from wild-type (E ) and mutant (F )
kidneys at E16.5 are shown. Condensed and
noninduced mesenchymal cells are lower in
number in Bmp4 / mutants. The percent-
age of apoptotic nuclei against total nuclei in
the metanephric mesenchyme (G ) is shown
in kidneys from wild-type (N  10) and mu-
tant (N 12) embryos. Mean values and stan-
dard errors from each group are also shown.
The difference is statistically significant by
Student t test (P 	 0.01).
Fig. 4. Ureteral smooth muscle development in
Bmp4 / embryos. Transverse sections of the
most cranial portion of the ureter are immuno-
stained for -smooth muscle actin (-SMA). Com-
pared to wild-type embryos (A) at E15.5, there are
a few smooth muscle cells surrounding the ureter
epithelium in Bmp4 / (B). Abbreviations are:
Ao, aorta; Ut, ureter epithelium; Kd, kidney. Bars
are 50 m. (C ) The percentage of -SMA-express-
ing cells against total mesenchymal cells around the
epithelium is shown at the most cranial portion of
wild-type (N  16) and mutant (N  12) ureters
at E15.5. Mean values and standard errors from
each group are also shown. The difference is statisti-
cally significant by Student t test (P 	 0.001).
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chamber at a concentration ranging from 0 to 30 ng/mL. abnormal cell death in the metanephric mesenchyme at
mid-stages can contribute to the development of hypo-In a pilot study, BMP4 at the above concentrations does
not change the number of viable cells (more than 90% dysplastic kidney in Bmp4 heterozygous mice.
of cells excluded trypan blue) after 24 hours of culture
BMP4 promotes expansion of the stromalcompared to vehicle alone. A polycarbonate membrane
mesenchyme and inhibits the condensation offilter (8 m pore size) (Neuro Probe, Inc., Cabin Jone,
the metenephric mesenchymeMD, USA) was placed between the bottom and top
chambers. The mesenchymal cell suspension was added Using an explant culture system, we next examined
whether BMP4 has direct actions on the metanephricto the top chamber at a cell density of 2 
 103/mm2. Af-
ter an 18-hour incubation, cells on the top of the filters mesenchyme. In whole metanephric explants, BMP4 uni-
formly inhibits the branching of the ureter (N  20)were scraped, the remaining cells were fixed with metha-
nol, and stained with hematoxylin. The number of cells (Fig. 2B), an observation consistent with earlier reports
[2, 11]. In addition, exogenous BMP4 down-regulatedwas determined under 
200 magnification at five ran-
dom fields. the expression of Pax2 and Bmp7 (N  14), markers for
the condensed mesenchyme, which surround the tip of
the branching ureters (Fig. 2 B, H). Histologic examina-
RESULTS
tions of tissue sections reveal that the condensation of
Enhanced apoptosis in the metanephric mesenchyme metanephric mesenchyme is inhibited around the ure-
of Bmp4 / embryos teric buds when explants were treated with BMP4 (data
not shown). Moreover, when the explants are treatedWe found earlier that the kidneys of Bmp4 / mice
at birth contain multicystic dysplastic regions, which are with both BMP4 and FGF2, the latter being a known
antiapoptotic factor for the metanephric mesenchymecompletely devoid of nephrogenic components, but filled
with cysts and stromal mesenchymal cells. This suggests [12], the peripheral portion of the mesenchyme increases
in size compared to explants with FGF2 alone (Figs. 2that BMP4 is also essential for later processes of kidney
development. In the present study, we examined apo- F, J, and 5 in reference [2]). The increase in size of this
portion is further confirmed by histologic analyses ofptotic activity in the mutant kidneys at E14.5 and E16.5,
as increased cell death has been reported prior to the tissue sections (data not shown). Whole mount in situ
hybridization reveals that this mesenchymal componentdevelopment of hypoplastic cystic kidneys in some mu-
tant mice [9, 10]. In wild-type embryos at E14.5, TUNEL- is negative for Bmp7 (N  14) (Fig. 2J) and Pax2 (Fig. 5
in reference [2]) and weakly and heterogeneously posi-positive cells are present in the developing nephron epi-
thelium and loose stromal cells located in the center of tive for Foxd1 (N  14) (Fig. 2F), a winged-helix tran-
scription factor that marks a peripheral undifferentiatedmetanephros, but hardly seen in the metanephric mesen-
chyme located in peripheral areas (Fig. 1A). By contrast, stromal cell population [13]. In this setting, the expres-
sion area of Bmp7, which is known to have survival andin/mutants, a large number of TUNEL-positive cells
is seen in the superficial metanephric mesenchymal area growth-promoting effects on the metanephric mesen-
chyme [14], is decreased in explants treated with BMP4(Fig. 1B). Quantitation of the results showed that, al-
though there is variation among mutant embryos, the (Fig. 2J).
number of apoptotic cells is significantly higher in /
BMP4 prevents cell death of the isolatedmutants than in wild-type embryos (% total metaneph-
metanephric mesenchymeric mesenchymal cells, Bmp4 /, 0.59  0.06, N  10;
Bmp4 /, 1.60  0.28, N  12, mean  SEM, P 	 Apart from the inhibitory effect of BMP4 on the con-
densed mesenchyme found in the above experiments,0.01 Student t test) (Fig. 1G). Moreover, analyses of
molecular markers in an adjacent section revealed that we next tested whether BMP4 can directly act as a sur-
vival factor for the isolated metanephric mesenchyme.TUNEL-positive cells of the mutant kidneys are mainly
located in the area that expresses Foxd1 (Fig. 1D), but Mesenchyme separated from the E11.5 ureteric bud epi-
thelium was cultured on filters in the presence of bovinenot Pax2 (Fig. 1C). Thus, Bmp4 / embryos have an
abnormally high apoptotic activity in the stromal compo- serum albumin (BSA)-, BMP4-, BMP7- or FGF2-soaked
beads and then incubated in medium with propidiumnents of metanephric mesenchyme at this stage. Note
that Bmp4 / kidneys already contain region that iodide, a fluorescent dye which can penetrate into dead
cells, but not living cells. While fluorescent label is uni-lacks superficial nephrogenic components at E16.5 (Fig.
1 E, F), while the apoptotic activity in the nephrogenic formly distributed in the control explants, it is distinc-
tively absent in cells adjacent to BMP4- (N 16), BMP7-zone is comparable between Bmp4/ and / em-
bryos at this stage (% total metanephric mesenchymal (N  8) or FGF2-soaked beads (N  7) (Fig. 3). The
rescue of cell death occurs only in close proximity to thecells, Bmp4 /, 0.47  0.05, N  11; Bmp4 /, 0.52
 0.13, N  10, mean  SEM). This suggests that an BMP4 beads (Fig. 3F), when compared to the FGF2-
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Fig. 2. Bone morphogenetic protein 4 (BMP4) inhibits induction of metanephric mesenchyme around the ureteric buds, and promotes expansion
of the peripheral stromal zone in the presence of fibroblast growth factor 2 (FGF2). Kidney rudiments dissected from E11.5 wild-type embryos
were cultured for 48 hours in the presence of vehicle alone (A, C, G ), 100 ng/mL of BMP4 (B, D, H ), 100 ng/mL of FGF2 (E, I ), or both BMP4
and FGF2 (F, J). The explants were subjected to whole mount in situ hybridization with a probe encoding Pax2 (A, B), Foxd1 (C to F), or Bmp7
(G to J). Each panel represents a typical result of more than 14 explants obtained from three independent experiments. BMP4 inhibits branching
of the ureters (B, H) and down regulates Pax2 (B) and Bmp7 (H) expression surrounding the ureteric buds (arrowheads). Treatment with both
BMP4 and FGF2 promotes expansion of Bmp7-negative (J) and Foxd1-weakly positive (F) stromal compartment of the metanephric mesenchyme
(arrows). Arrowheads indicate an edge of the explants. Bars are 300 m.
beads (Fig. 3H). However, the degree is comparable be- to form a distinctive smooth muscle layer. In this process,
whereas the expression of Bmp4 is uniformly seen in thetween BMP4 and BMP7 beads (Fig. 3 F, G). Similar
results were also seen when BMP4 or FGF2 was added ureter mesenchyme at early developmental stages, its ex-
pression becomes localized to an area where the smoothdirectly to the culture medium, although the degree of
antiapoptotic effect of BMP4 is lower than that of FGF2 muscle layer develops at later stages [2]. This suggests
that BMP4 has a regulatory role in the development(data not shown). These results indicate that BMP4, act-
ing on the metanephric mesenchyme, prevents death of smooth muscle of the urinary tract. At E15.5, the
periureteral mesenchymal cells begin to express -SMA,of the mesenchymal cells and promotes increase in cell
number of the stromal cell population in the presence an early marker for smooth muscle cells, in wild-type
of FGF2. embryos at the cranial portion of the ureter. We there-
fore examined the expression of -SMA in the periure-
Defective smooth muscle development of the ureter teral mesenchyme at this stage. Immunostaining with
in Bmp4 / embryos -SMA antibody reveals that the number of -SMA–
positive cells is significantly lower in mutants than inDuring embryonic development of the ureter, periure-
teral mesenchymal cells condense around the epithelium wild-type embryos (% total ureter mesenchymal cells,
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Fig. 3. Bone morphogenetic protein 4 (BMP4) prevents cell death of the metanephric mesenchyme. Isolated metaneprhic mesenchymes obtained
from E11.5 embryos were cultured for 24 hours in the presence of (A, E ) bovine serum albumin (BSA)-, (B, F ) 3 g/mL BMP4-, (C, G ) 3 g/mL
BMP7-, or (D, H ) 3 g/mL fibroblast growth factor 2 (FGF2)-soaked beads, and incubated with 2.5 g/mL propidium iodide for 30 minutes. The
explants were observed under the microscope with (E to G) or (A to D) without a fluorescence. In BMP4 beads (N  16), BMP7 beads (N 
8), and FGF2 beads (N  7), cells adjacent to the beads do not fluoresce, while, in the control explants (N  9), mesenchymal cells show fluorescent
signals around the beads. The heparin acrylic bead (C and F) shows an autofluorescence. Bars are 200 m.
/, 28.4  1.2%, N  16; /, 16.4  1.4%, N  12, cell proliferation (data not shown), nor prevent cell death
(Fig. 5 J, K), in the mesenchymal cells surrounding themean  SEM, P 	 0.001 Student t test) (Fig. 4 A, B).
At this stage, the size of the ureter lumen and the mor- beads, the beads promote the accumulation of the mes-
enchymal cells to form several layers surrounding thephology of the ureter epithelium are comparable be-
tween wild-type and mutant embryos (Fig. 4 A, B). Thus, beads, which is not seen in control BSA beads (Fig. 5
A to C). Similar results were obtained in three replicatethe reduced expression of the smooth muscle marker in
mutant ureters is not likely a result of a mechanical injury experiments (Fig. 5 D to I). Quantitation of cell number
revealed that the density of mesenchymal cells signifi-due to a possible obstructive uropathy as previously spec-
ulated [2]. cantly increases around the 10 g/mL BMP4 bead (cell
density, 1.48  0.07 
 102/m2, N  7, mean  SEM),
BMP4 promotes migration of ureter when compared to the control BSA bead (0.9  0.04 

mesenchymal cells 102/m2, N  7; mean  SEM, P 	 0.05) (Fig. 5L).
These results suggest that a localized, not diffuse, highWe next examined whether smooth muscle cells can
concentration of BMP4 is important for the inductionbe induced by BMP4 in explant culture system. When
of the ureter smooth muscle and that BMP4 can serveE12.0 ureter rudiments are cultured on filters for 72
as a chemoattractant for the periureteral mesenchymalhours in the absence of exogenous BMP4, -SMA ex-
pression is seen in the mesenchymal cells that condense cells. To examine the chemotactic activity of BMP4, a
modified Boyden chamber assay was performed for dis-around the ureter epithelium. Addition of exogenous
BMP4 (30 to 300 ng/mL) to the medium does not cause sociated periureteral mesenchymal cells. Addition of
BMP4 (30 ng/mL) to the bottom chamber shows a sig-an increase in the number of -SMA–positive cells nor
a change in 5-bromo-2-deoxyuridine (BrdU) incorpora- nificant increase in the cell migration through the mem-
brane (number of migrating cells, control, 23.9 3.2, Ntion or TUNEL positivity (data not shown). In the next
experiments, BMP4-soaked beads were placed in the 11; BMP4, 54.0  3.2, N  12, mean  SEM, P 	 0.001)
(Fig. 5M). The increase in cell migration is not seen (23.6mesenchyme surrounding the ureter epithelium. While
BMP4 beads neither induce -SMA expression, promote 4.2, N  10), when treated with PDGF-BB, which is
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implicated in the chemoattraction of vascular smooth and weakly Foxd1-positive stromal zone of the meta-
nephric mesenchyme in the whole metanephric explantsmuscle cells [15]. Moreover, addition of BMP4 to both
the bottom and top chambers attenuates migration of (Figs. 2 and 5 in reference [2]). Moreover, exogenous
BMP4 down-regulates Pax2 and Bmp7 expression thatthe cells, when compared to the bottom chamber alone
(35.3  3.6, N  10, P 	 0.01) (Fig. 5M), suggesting that surrounds the ureteric bud, and inhibits the condensation
of the metanephric mesenchyme (Fig. 2). This observa-the migration of the cells through the membrane is due,
at least in part, to a chemotactic effect of BMP4. Thus, tion is consistent with the previous finding that BMP4
attenuated tubulogenesis in the isolated metanephricBMP4 can induce attractive chemotaxis, thereby pro-
moting condensation of the mesenchymal cells along the mesenchyme induced by the spinal cord or lithium chlo-
ride [11]. Collectively, these in vivo and in vitro observa-ureter epithelium.
tions indicate that BMP4 can act on the metanephric
mesenchyme to regulate its growth and differentiation.
DISCUSSION
With regard to the inhibitory effect of BMP4 on the
In this study, we show that the development of the dys- development of the condensed mesenchyme, however,
plastic regions seen in the kidneys of Bmp4/ embryos the possibility remains that the loss of Pax2 or Bmp7
at E16.5 are preceded by enhanced apoptosis in the stro- expression is related to an increase in cell death, since
mal cell population of metanephric mesenchyme in mu- a large quantity of TUNEL-positive cells are seen in the
tant embryos (Fig. 1). A similar pathophysiologic process condensed mesenchyme that surrounds the BMP4 bead,
has been reported for the formation of hypo/dysplastic but not the control bead (Fig. 5 J, K). The data from
kidney in other mutant mice. For example, in mice carry- TUNEL-positive cells in the condenced metanephric mes-
ing null mutations of the Bcl2 or Bmp7 genes, the devel- enchyme appear to argue against the antiapoptotic effect
opment of hypo/dysplastic kidney is preceded by flumi- of BMP4 shown in Figure 3. However, the condensed
nant apoptosis of the metanephric mesenchyme during metantphric mesenchyme, which is positive for Pax2 or
the mid-stage of nephrogenesis [9, 10]. In Bmp4/ mu- Bmp7, is small fraction of the total isolated mesenchyme
tants from E12.5 to E14.5, while nephron number per shown in Figure 3. In support of the latter, it has been
kidney is appreciably reduced, the nephron density per se reported earlier that isolated mesenchyme has a uniformly
and the overall morphology are well preserved. How- low level of Foxd1, but they completely lacks expression
ever, the dysplastic lesion develops at E16.5 (Fig. 1F), just of Pax2 [14]. In this study, we cannot determine whether
2 days after the enhanced apoptosis occurs in the stromal BMP4 directly induces apoptosis of nephrogenic mesen-
population of the metanephric mesenchyme (Fig. 1B). chyme, or inhibits the differentiation of the mesenchyme,
The dysplastic morphorlogy seen in Bmp4 heterozygozes which, in turn, undergoes apoptosis.
is characterized by two lesions, one of which is local The observed effects of BMP4 are reminiscent of those
loss of nephrogenic components and the other is cystic of BMP7 on the metanephric mesenchyme. Thus, BMP7
dilatation of tubules and glomeruli. We speculate with- has been shown to prevent cell death, inhibit tubulogen-
out conclusive evidence that the enhanced apoptosis esis, and promote expansion of stromal progenitor cell
in the stromal metanephric mesenchyme at E14.5 con- population in the presence of FGF2, thereby preserving
tributes to the development of the former abnormality. the metenephric mesenchymal cell population at the tip
Other pathophysiologic processes can be involved in the of the branching ureters [14]. It has been shown that a
formation of cystic region, given the potentially multiple functional redundancy exists among the members of BMP
biologic effects of BMP4, however. superfamily during the embryonic development [1], and
The observed enhanced apoptosis in the mutant meta- BMP4 and 7 have a binding affinity to the same BMP re-
nephric mesenchyme can be a result of a deficiency in ceptors [16, 17], for example, Bmpr1a (Alk3) and Bmpr1b
antiapoptotic factors derived from the ureteric bud. In (Alk6), the former being intensely expressed in meta-
support of this possibility, previous studies suggested nephric mesenchyme [2, 6]. It is conceivable, therefore,
that BMP4, acting on the ureter epithelium, stimulates that BMP4 and 7 share a common receptor-signaling path-
the growth and elongation of the ureter bud and pro- way and identical effects on the development of meta-
motes overall branching morphogenesis of the ureter [2]. nephric mesenchyme. In this regard, one may argue that
To determine whether BMP4 has a direct antiapoptotic the observed effects of BMP4 on the metanephric mesen-
effect on the metanephric mesenchyme, we performed chyme (Figs. 2 and 3) merely mimic those of BMP7, since,
in vitro experiments on the metenephric mesenchyme. unlike BMP7, BMP4 is not expressed in the metanephric
In the isolated metanephric mesenchyme, BMP4-soaked mesenchyme [2, 5], and BMP4 appears to have only a
beads uniformly prevented cell death of the metanephric short-range effect as shown (Fig. 3). However, in addi-
mesenchyme locally (Fig. 3). In addition, in the presence tion to the loose stromal mesenchyme that surrounds the
of exogenous FGF2, treatment with BMP4 led to an branching ureter, Bmp4 is also distinctively expressed in
the superficial capsule of the developing kidney (Fig. 1increase in cell number of the Pax2- and Bmp7-negative
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Fig. 5. Bone morphgenetic protein 4 (BMP4) induces an attractive chemotaxis for the periureteral mesenchymal cells. Bovine serum albumin
(BSA) control beads (A, D, G ), 3 g/mL (B, E, H ), or 10 g/mL (C, F, I ) BMP4 beads were placed in the mesenchyme that surrounds the
epithelium of the ureter explants dissected from E12.0 embryos. After incubation for 24 hours, the explants were routinely processed, sectioned,
and stained with hematoxylin. BMP4 beads at both 3 g/mL (N  10) and 10 g/mL (N  15) concentrations, but not control beads, form several
mesenchymal cell layers around the beads. (A to C), (D to F) and (G to I) are from three independent experiments, respectively. Ut is ureter
epithelium. Bar is 100 m. Sections were subjected to terminal deoxy transferase uridine triphosphate nick end-labeling TUNEL staining. Compared
to the BSA bead ( J ), a larger number of apoptotic cells are present in the metanephric mesenchyme (arrowheads) around the BMP4 bead (K ).
Note that apoptotic activity is comparable in the periureteral mesenchyme between these two beads. The density of periureteral mesenchymal
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d, f in reference [2]). Furthermore, in Bmp4 / em- ureter smooth muscle layer. Moreover, in a modified Boy-
bryos that selectively lack Bmp4, but not Bmp7, a large den chamber assay, BMP4 promotes chemotaxis of peri-
number of apoptotic cells are seen in the most peripheral uretral mesenchymal cells through the filter, and the mi-
portion of the metanephric mesenchyme just beneath gration is inhibited when BMP4 is present in both top
the kidney capsule (Fig. 1). In these heterozygotes, the and bottom chambers (Fig. 5). Thus, these in vitro ob-
onset and distribution of the mesenchyme apoptosis servations indicate that BMP4 acts as a chemoattractant
closely resemble those in Bmp7 null mutant embryos for the periureteral mesenchymal cells. A similar chemo-
[5]. The present study, therefore, indicates that full gene taxis-promoting effect of BMPs has been reported pre-
and protein dosages of both BMP4 and BMP7 are re- viously. For example, BMP2 has been shown to induce
quired for the normal development of the metanephric chemotaxis of human monocytes [18], vascular aortic
mesenchyme. smooth muscle cells [19], and corneal fibroblasts [20].
In addition to the effects on the metanephric mesen- It remains uncertain to date whether the formation of
chyme, it appears that BMP4 has a different effect on the the ureter smooth muscle is preceded by the recruitment
development of the periureteral mesenchyme, namely, of the local mesenchymal cells. While BMP4 can induce
induction of the smooth muscle layer at the site where migration and condensation of the mesenchyme around
BMP4 is intensely expressed around the ureter epithe- the ureter epithelium by its attractive chemotactic activ-
lium. In wild-type embryos, -SMA is expressed in the ity, BMP4 alone is not sufficient for differentiation into
periureteral mesenchyme as early as E15.5. At this stage, smooth muscle cells, since BMP4 beads do not induce
the -SMA-expressing cells are significantly lower in -SMA expression in the accumulated mesenchymal
number in Bmp4 / embryos than wild type (Fig. 4), cells around the beads. Thus, we cannot conclude in the
while the gross appearance of the ureter epithelium is present study that the chemotactic effect of BMP4 is
not changed. At later stages, the poor development of the indeed essential for the development of the ureter
muscle layer is more distinctively seen in some of the smooth muscle. In this regard, it has been shown that
mutant embryos, but, at the same time, accompanied by the interaction of the mesenchyme with the epithelium
a change in the overall morphology of the ureter (e.g., is critical for the differentiation into the visceral smooth
dilated lumen, flattened epithelium, and tortuous struc- muscle, as revealed by experiments on tissue recombi-
ture) [2]. As reported previously, Bmp4 / mutants nants of embryonic uterus [21], stomach [22], and bladder
show an ectopic ureterovesical junction, which can cause [23]. In embryonic ureters, smooth muscle differentiation
an obstructive uropathy [2]. Thus, the possibility re- is induced in the region somewhat distant from the epi-
mained that the hypoplasia of the ureter smooth muscle thelium, where Bmp4 is intensely expressed. Thus, it is
is attributed merely to a mechanical injury as a result of likely that BMP4 determines the site of the periureteral
obstruction, but not to an intrinsic defect of smooth mesenchymal condensation, which, in turn, undergoes
muscle development. We, therefore, performed in vitro differentiation into smooth muscle layer through a path-
experiments to test whether BMP4 has a local regulatory way governed by the epithelium [24, 25].
role on the induction of the ureter smooth muscle. Using
the ureteric tissues separated from the metanephros, ad-
CONCLUSIONdition of BMP4 to the culture medium did not promote
In summary, BMP4 can have multiple biologic func-smooth muscle development, but caused a slight decrease
tions on the morphogenesis of individual tissues of thein the thickness of the whole explants without a change in
excretory system (i.e., the development of the kidney,cell proliferation not cell death. By contrast, BMP4-soaked
the ureter and the ureterovesical junction). Results frombeads, when placed in the mesenchyme surrounding the
the present study suggest that BMP4, acting on the meta-ureter epithelium, promote accumulation of the mesen-
nephric mesenchyme, prevents cell death and promoteschymal cells to form several layers around the beads
the growth of the stromal component. In addition, BMP4(Fig. 5), with no change in cell proliferation or cell death.
inhibits condensation of the nephrogenic mesenchymeThis suggests that a localized, not diffuse, high concen-
tration of BMP4 is required prior to the induction of the either via a direct action on the mesenchyme or an indi-

cells is shown (L ) as the cell number within the area as far as 25 m in distance from the bead per square micrometer. The density is significantly
higher for 10 g/mL BMP4 beads than control beads. The number of migrating cells is shown (M ) in a modified Boyden chamber assay. Dissociated
periureteral mesenchymal cells are placed on a membrane with 8 m pores and incubated for 18 hours. The migrating cells through the membrane
are fixed, stained, and counted under 
200 magnification at random five fields. Addition of BMP4 to the bottom chamber increases the number
of migrating cells. Addition of BMP4 to both chambers inhibits the migration. Addition of platelet-derived growth factor (PDGF)-BB has no
effect. Values are expressed as mean  SEM. *P 	 0.001 vs. control; #P 	 0.01 vs. BMP4 in the bottom chamber alone by analysis of variance
(ANOVA) followed by Bonferroni test.
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